Astellas Pharma (OTCMKTS:ALPMY – Get Free Report) issued its earnings results on Thursday. The company reported $0.11 EPS for the quarter, reports. Astellas Pharma had a return on equity of 5.85% and a net margin of 1.20%. The company had revenue of $2.79 billion during the quarter.
Astellas Pharma Stock Performance
ALPMY opened at $9.55 on Friday. The business has a fifty day simple moving average of $10.53 and a 200 day simple moving average of $11.45. The company has a market capitalization of $17.28 billion, a PE ratio of 27.26, a price-to-earnings-growth ratio of 1.65 and a beta of 0.32. Astellas Pharma has a 1 year low of $9.15 and a 1 year high of $16.91. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.91 and a quick ratio of 0.71.
About Astellas Pharma
Featured Articles
- Five stocks we like better than Astellas Pharma
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- MarketBeat Week in Review – 4/22 – 4/26
- 5 Top Rated Dividend Stocks to Consider
- 3 Stocks Leading the U.S. Agriculture Comeback
- Options Trading – Understanding Strike Price
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Astellas Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astellas Pharma and related companies with MarketBeat.com's FREE daily email newsletter.